Evidence map›Paper›PMID 36926128›Full record

ReviewWorld journal of clinical cases2023

Implications of metabolic dysfunction associated fatty liver disease in COVID-19.

Raja Chakraborty, Deepak Sharma, Devesh U Kapoor, Akanksha Dwivedi, Rakhi Khabiya, Saikat Sen

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of clinical cases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Raja ChakrabortyInstitute of Pharmacy, Assam Don Bosco University, Guwahati 782402, Assam, India.
Deepak SharmaSchool of Medical Sciences, Adamas University, Kolkata 700126, West Bengal, India.
Devesh U KapoorDepartment of Pharmacy, Dr. Dayaram Patel Pharmacy College, Bardoli 394601, Gujarat, India.
Akanksha DwivediDepartment of Pharmacy, Acropolis Institute of Pharmaceutical Education & Research, Indore 453771, Madhya Pradesh, India.
Rakhi KhabiyaDepartment of Pharmacy, Acropolis Institute of Pharmaceutical Education & Research, Indore 453771, Madhya Pradesh, India.
Saikat SenFaculty of Pharmaceutical Science, Assam down town University, Guwahati 781026, Assam, India. saikat.pharm@rediffmail.com.
Assam Don Bosco University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic associated fatty liver disorder (MAFLD) characterizes the contributing etiologies (

Indexed as

COVID-19Cytokine stormHepatic damageMetabolic associated fatty liver disorderMetabolic dysfunction

Identifiers

PMID36926128
PMCPMC10013103
OpenAlexW4321464113

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.